Yuxi Global

Yuxi Global, operating under the Veritas Automata umbrella, has been running development shops for life sciences clients since 2005. That's two decades of shipping enterprise software into regulated verticals - pharma, biotech, medical devices - where a misconfigured pipeline or an unpatched dependency isn't just an inconvenience, it's an FDA letter. The threat model here isn't nation-state APTs; it's the quieter risk of technical debt accumulating in systems that handle clinical data, supply chain logistics, and manufacturing workflows where integrity failures have real downstream consequences. The company fields over 150 IT professionals across Miami and the Americas, working on stacks anchored in Microsoft Azure and AWS , with Kubernetes orchestration, .NET and Node.js backends, and React frontends. They operate through managed development teams and staff augmentation - embedding engineers directly into client orgs rather than handing off deliverables and walking away. Nearly 300 clients over the life of the company, with an average relationship lasting more than seven years, which in IT services is less about loyalty and more about the switching costs of domain-specific knowledge in regulated environments. Beyond life sciences, they've extended into transportation, manufacturing, and supply chain - sectors that share a common thread: operational technology meeting enterprise software, where uptime and data integrity aren't negotiable. If you're looking at this from a security angle, the interesting question is how they handle the intersection of compliance frameworks, CI/CD pipeline security, and the reality of maintaining long-lived applications across heavily audited industries.